13G OVAS 2-14-2014

Company

Tempest Therapeutics, Inc.

Filed

February 14, 2014

Accession Number

0000812295-14-000082

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →